Login / Signup

Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma.

Adi KartoloCynthia YeungMarkus KuksisWilma HopmanTara Baetz
Published in: Melanoma management (2022)
V600 wild-type advanced melanoma patients.
Keyphrases
  • wild type
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • free survival